Korsana Biosciences, Inc. (KRSA) insider trading.
In Q3 2026, insiders at Korsana Biosciences, Inc. reported 4 non-derivative transactions on 15 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 3
- Last filed
- 2026-08-18
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Graul Regina Margaret | Director, Officer · See Remarks | 2 | 0 | 0 |
| Chicko Rhonda M. | Officer · Chief Financial Officer | 1 | 0 | 0 |
| Hecht Peter M | Director, TenPercentOwner | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-14 | Graul Regina Margaret | F (D) | 48,629 | $3.79 | 107,523 | Form 4 |
| 2026-08-14 | Graul Regina Margaret | M (A) | 55,849 | $3.3 | 156,152 | Form 4 |
| 2026-08-14 | Chicko Rhonda M. | M (A) | 25,000 | $2.36 | 25,018 | Form 4 |
| 2026-07-16 | Hecht Peter M | C (A) | 351,037 | — | 910,240 | Form 4 |
Transaction codes in this quarter
Get KRSA insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1755237&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · KRSA company page · Korsana Biosciences, Inc. on SEC.gov
Questions
Are insiders buying or selling Korsana Biosciences, Inc. (KRSA)?
In Q3 2026, insiders at Korsana Biosciences, Inc. reported 4 non-derivative transactions on 15 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Korsana Biosciences, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/krsa.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.